Gilead Tumbles On Q2 Earnings Beat, Light Full-Year Guidance

Gilead Sciences (GILD) is falling Tuesday despite reporting better-than-expected second-quarter earnings, as its full year guidance was just shy of expectations. The company said that it earned $3.08 a share on revenue of $7.78 billion. Analysts were looking for earnings of $30.1 on revenue of $7.8 billion. For the full year Gilead expects product sales […]